{
    "nct_id": "NCT03304587",
    "official_title": "Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors: A Personalized Intervention",
    "inclusion_criteria": "* Females\n* 21 years of age or older 1-3 years post-completion of chemotherapy or/and radiation therapy for stage I-III breast cancer\n* Experience ≥ 2 concurrent symptoms (fatigue, sleep disruption, depressive symptoms, and/or cognitive dysfunction as measured by 4 screening instruments)\n* Be either phase advanced or delayed (morning or evening types by the Horne-Ostberg Morningness-Eveningness Questionnaire (MEQ) ≥59 or ≤41)\n* Sighted\n* Mentally competent to consent\n* Able to understand English.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 21 Years",
    "exclusion_criteria": "* Undergoing cancer treatment for another malignancy\n* Have metastatic cancer\n* Engaged in shift work or travel across more than three time zones within 2 weeks prior to study\n* Current diagnosis of seasonal affective disorder or substance abuse Current diagnosis of major Axis I psychiatric disorders (e.g. depressive disorders), neurological impairments, or muscular dystrophies\n* Report severe depressive mood (Center for Epidemiological Studies Depression Scale (CES-D) >24)\n* Take prescribed sedative hypnotics or steroids Have eye conditions (glaucoma or retinal disease), problems triggered by bright light (e.g., migraine), or take photosensitizing medications (e.g., some porphyrin drugs, antipsychotics, antiarrhythmic agents)",
    "miscellaneous_criteria": ""
}